Pulmonx (LUNG) Equity Ratio (2019 - 2025)

Pulmonx (LUNG) has 7 years of Equity Ratio data on file, last reported at 0.42 in Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.42, down 20.56% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.42 (down 20.56% YoY), and the FY2025 annual result was 0.42, down 20.56% from the prior year.
• Equity Ratio slipped to 0.42 in Q4 2025 per LUNG's latest filing, from 0.43 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.85 in Q1 2021 and troughed at 0.42 in Q4 2025.
• A 5-year average of 0.67 and a median of 0.69 in 2023 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2021 and 2025: Equity Ratio soared 128.3% in 2021, then decreased 23.25% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.82 in 2021, then decreased by 3.23% to 0.8 in 2022, then fell by 16.31% to 0.67 in 2023, then slipped by 20.82% to 0.53 in 2024, then slipped by 20.56% to 0.42 in 2025.
• Business Quant data shows LUNG's Equity Ratio at 0.42 in Q4 2025, 0.43 in Q3 2025, and 0.47 in Q2 2025.